GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
V

Vitrolife VITR.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

119.60

-0.42%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in SEK, from our data supplier.

FY2025

Revenue

SEK 3.44bn

FY2016FY2025

Net income

−SEK 5.01bn

FY2016FY2025

Free cash flow

SEK 460.0m

FY2016FY2025

Shareholders' equity

SEK 7.89bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueSEK 3.44bnSEK 3.61bnSEK 3.51bnSEK 3.23bnSEK 1.68bnSEK 1.25bnSEK 1.48bnSEK 1.15bnSEK 1.05bnSEK 856.1m
Gross profitSEK 1.75bnSEK 2.13bnSEK 1.98bnSEK 1.79bnSEK 1.05bnSEK 767.7mSEK 938.7mSEK 761.1mSEK 681.7mSEK 561.3m
Research and developmentSEK 111.0mSEK 117.0mSEK 228.0mSEK 143.0mSEK 114.5mSEK 91.8mSEK 99.5mSEK 88.5mSEK 69.1mSEK 61.6m
Operating incomeSEK 616.0mSEK 783.0m−SEK 3.60bnSEK 654.0mSEK 445.0mSEK 370.0mSEK 488.7mSEK 393.9mSEK 340.9mSEK 249.2m
Net income−SEK 5.01bnSEK 513.0m−SEK 3.85bnSEK 394.0mSEK 341.0mSEK 286.8mSEK 382.8mSEK 309.7mSEK 263.6mSEK 190.4m
Diluted earnings per share-37.023.78-28.442.913.172.643.532.852.431.75

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsSEK 11.12bnSEK 17.45bnSEK 16.33bnSEK 20.55bnSEK 19.43bnSEK 2.31bnSEK 2.14bnSEK 1.70bnSEK 1.42bnSEK 1.25bn
Cash and short-term investmentsSEK 809.0mSEK 1.14bnSEK 861.0mSEK 578.0mSEK 630.1mSEK 973.6mSEK 689.5mSEK 490.8mSEK 396.0mSEK 189.2m
Total liabilitiesSEK 3.23bnSEK 3.81bnSEK 3.61bnSEK 3.81bnSEK 4.09bnSEK 288.1mSEK 341.1mSEK 201.3mSEK 193.8mSEK 230.1m
DebtSEK 1.60bnSEK 2.09bnSEK 2.09bnSEK 2.23bnSEK 2.48bnSEK 62.4mSEK 75.8m—SEK 480,000SEK 37.9m
Shareholders' equitySEK 7.89bnSEK 13.64bnSEK 12.72bnSEK 16.74bnSEK 15.32bnSEK 2.01bnSEK 1.79bnSEK 1.49bnSEK 1.23bnSEK 1.02bn
Shares outstanding135m136m135m135m108m109m109m109m109m109m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsSEK 635.0mSEK 907.0mSEK 757.0mSEK 636.0mSEK 384.3mSEK 356.4mSEK 413.3mSEK 349.4mSEK 312.2mSEK 181.3m
Capital spending−SEK 175.0m−SEK 92.0m−SEK 119.0m−SEK 87.0m−SEK 62.4m−SEK 20.1m−SEK 87.1m−SEK 180.1m−SEK 10.5m−SEK 13.8m
Free cash flowSEK 460.0mSEK 815.0mSEK 638.0mSEK 549.0mSEK 321.9mSEK 336.4mSEK 326.2mSEK 169.3mSEK 301.7mSEK 167.5m
Dividends paid−SEK 149.0m−SEK 135.0m−SEK 115.0m−SEK 110.0m−SEK 88.3m−SEK 88.3m−SEK 92.3m−SEK 81.0m−SEK 57.0m−SEK 52.5m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueSEK 857.0mSEK 807.0mSEK 891.0mSEK 835.0mSEK 871.0mSEK 842.0mSEK 959.0mSEK 867.0m
Gross profitSEK 517.0mSEK 483.0mSEK 322.0mSEK 499.0mSEK 505.0mSEK 483.0mSEK 586.0mSEK 508.0m
Operating incomeSEK 198.0mSEK 149.0mSEK 159.0mSEK 155.0mSEK 137.0mSEK 151.0mSEK 225.0mSEK 174.0m
Net incomeSEK 129.0mSEK 101.0m−SEK 5.31bnSEK 102.0mSEK 100.0mSEK 100.0mSEK 139.0mSEK 116.0m
Diluted earnings per share0.950.75-39.240.750.740.741.030.86
Cash from operationsSEK 140.0mSEK 172.0mSEK 160.0mSEK 255.0mSEK 151.0mSEK 69.0mSEK 268.0mSEK 206.0m
Capital spending−SEK 34.0m−SEK 44.0m−SEK 20.0m−SEK 56.0m−SEK 100.0m−SEK 39.0m−SEK 31.0m−SEK 46.0m
Free cash flowSEK 106.0mSEK 128.0mSEK 140.0mSEK 199.0mSEK 51.0mSEK 30.0mSEK 237.0mSEK 160.0m
Total assetsSEK 11.30bnSEK 11.24bnSEK 11.12bnSEK 16.85bnSEK 16.86bnSEK 16.63bnSEK 17.45bnSEK 16.88bn
Cash and short-term investmentsSEK 823.0mSEK 886.0mSEK 809.0mSEK 1.11bnSEK 921.0mSEK 1.05bnSEK 1.14bnSEK 925.0m
DebtSEK 1.52bnSEK 1.50bnSEK 1.65bnSEK 2.00bnSEK 1.99bnSEK 1.95bnSEK 2.09bnSEK 1.96bn
Shareholders' equitySEK 8.13bnSEK 8.07bnSEK 7.89bnSEK 13.30bnSEK 13.28bnSEK 13.13bnSEK 13.64bnSEK 13.14bn

Financial ratios

Data as of 2 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin50.9%59.1%56.3%55.3%62.3%61.6%
Operating margin17.9%21.7%-102.5%20.2%26.5%29.7%
Net margin-145.7%14.2%-109.7%12.2%20.3%23.0%
Return on equity-63.5%3.8%-30.3%2.4%2.2%14.3%
Return on assets-45.1%2.9%-23.6%1.9%1.8%12.4%
Free cash flow yield6.5%8.1%7.1%5.8%4.5%3.8%
Revenue growth-4.7%2.8%8.6%92.4%34.9%-15.8%
Earnings growth-1077.2%-113.3%-1077.4%15.5%18.9%-25.1%
Current ratio3.40x3.34x3.44x2.53x1.47x7.99x
Debt to equity0.19x0.15x0.16x0.13x0.16x0.01x
Equity ratio71.0%78.2%77.9%81.4%78.9%87.3%
Interest coverage7.08x7.18x-35.29x10.90x44.50x177.47x
R&D as a share of sales3.2%3.2%6.5%4.4%6.8%7.4%
Buybacks as a share of market value0.1%-0.1%0.0%-25.8%0.9%0.0%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue2.1%22.5%16.9%
Operating income-2.0%10.7%10.5%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin55.1%55.4%56.6%58.6%
Operating margin19.8%-11.2%-4.4%4.4%
Net margin-63.8%-57.7%-43.8%-27.3%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-3.756.8-6.864.0176.781.756.051.551.344.1
Price to sales5.48.17.57.835.918.814.513.912.99.8

Dividends and splits

Per share, in the currency the company pays

Paid for 5 years. Last went ex-dividend on 6 May 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2019FY2018
Paid in the year1.101.102.000.850.800.800.850.74
  • 5-for-1 split · 17 May 2018

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.